MedPath

NOVO-BUPROPION SR TABLETS

NOVO-BUPROPION SR TABLETS

Discontinued
DIN Number

02260239

Drug Class

Human

Market Date

Mar 30, 2005

Company
HC

novopharm limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02260239
AIG Number0131140003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N06AX12 BUPROPION
Product Specifications
Dosage FormTablet (Extended-Release)
Route of AdministrationOral
AHFS Classification28:16.04.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

BUPROPION HYDROCHLORIDEActive
Strength: 150 MG
Monograph: BUPROPION HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.